本文へ移動
cccskills
無料GitHub で公開

enda-preliminary-cortisol-acth-test

Suggests using morning cortisol ≤140 nmol/L (5 µg/dL) in combination with ACTH as a preliminary test suggestive of primary adrenal insufficiency when a corticotropin stimulation test is not feasible. Use when patients present with indicative symptoms such as hypotension, hyponatremia, hyperkalemia, or fatigue and corticotropin stimulation testing cannot be performed.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md2.8 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Use Morning Cortisol and ACTH as Preliminary Test for PAI

STEP 1 — Gather Information

Collect morning plasma cortisol (drawn 6–10 AM) and plasma ACTH; assess clinical signs suggestive of PAI (e.g., hypotension, hyponatremia, hyperkalemia, fatigue, weight loss, hyperpigmentation). If corticotropin stimulation test is not feasible, proceed.

STEP 2 — Rule In / Rule Out

Apply cutoff: morning cortisol ≤140 nmol/L (5 µg/dL) AND ACTH >2× upper limit of reference range (or elevated per assay). If both criteria met, rule in possible PAI; if cortisol >140 nmol/L or ACTH not elevated, rule out PAI for now and consider alternative diagnoses.

STEP 3 — Classify or Stratify

If ruled in, classify as preliminary suggestive of primary adrenal insufficiency; note that confirmatory corticotropin stimulation test should be performed when feasible. If ruled out, consider other causes of adrenal insufficiency or non-adrenal etiologies.

STEP 4 — Decide

If preliminary test suggestive, initiate stress-dose glucocorticoid therapy if patient is acutely ill or adrenal crisis suspected, and arrange for corticotropin stimulation test as soon as possible; otherwise, schedule confirmatory test and educate patient on adrenal crisis prevention.

Clinical Guardrails / Mimics / Pitfalls

Do not rely solely on this preliminary test for definitive diagnosis; avoid using in community-based screening; beware of estrogen-containing medications that raise CBG and cortisol, which may falsely normalize cortisol; remember that ACTH assays vary and a single elevated ACTH may be spurious; do not delay definitive testing when corticotropin stimulation becomes available.

Concrete Clinical Example

A 58‑year‑old woman presents with fatigue, postural hypotension, and serum sodium 128 mmol/L. Morning cortisol is 110 nmol/L (4 µg/dL) and ACTH is 85 pmol/L (reference <45 pmol/L). Corticotropin stimulation test is delayed due to equipment unavailability. Preliminary test meets criteria (cortisol ≤140 nmol/L, ACTH >2× ULN), so she is started on hydrocortisone 15 mg morning, 10 mg afternoon and referred for prompt stim test.

Source: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, https://doi.org/10.1210/jc.2015-1710

TODO: consider adding scripts/calc.py for the enda-preliminary-cortisol-acth-test calculator

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する